Paige Sharpe's practice focuses on complex commercial litigation, primarily mass torts and product liability actions involving consumer products and prescription drugs. She represents major U.S. companies in defending against personal injury claims in state and federal court and at both trial court and appellate court levels, and she also advises clients on their response to government investigations. Her practice also includes class action defense and advising food companies on mitigating the risks associated with ultra-processed foods (“UPF”). Her experience includes counseling clients on litigation risks, coordinating discovery and trial strategies across multiple jurisdictions, and helping manage the litigation and regulatory matters that arise out of product safety issues.
Paige maintains an active pro bono practice and has worked on a range of matters, including a wrongful death suit against city and state police officers and criminal defense work. Most recently, she served as the lead trial lawyer in a federal court case challenging a state method of execution as cruel and unusual.
Before starting law school, Paige worked on the copydesks of two Southeastern newspapers.
Experience
- Sanofi as national counsel in product liability litigation concerning Zantac. Appointed to defense steering committee in In re Zantac (ranitidine) Prods. Liab. Litig., MDL No. 2924 (S.D. Fla.).
- Galderma in consumer fraud class action litigation involving a skin care product.
- Food companies in advising on risk mitigation associated with ultra-processed foods.
- Pharmaceutical companies in advising on litigation risk management associated with nitrosamine testing and regulatory reporting.
- Bristol-Myers Squibb and Sanofi as national counsel in Plavix product liability and state attorney general litigation.
- Bristol-Myers Squibb as national counsel in Abilify product liability litigation.
- Sanofi in product liability litigation concerning thalidomide.
- Biopharmaceutical company as national counsel in state APA litigation regarding patient access to a novel prescription therapy.
- Consumer product company in class action litigation related to an alleged product safety hazard.
- Fortune 500 company in breach-of-contract litigation against supplier related to a product recall.
Perspectives
Recognition
"Recommended Lawyer" Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices — Defense (2017, 2021-2022)
Credentials
Education
- J.D., University of North Carolina at Chapel Hill School of Law, 2007, high honors, Order of the Coif
- M.A., University of Virginia, 1999
- B.A., Randolph-Macon Woman's College, 1997, summa cum laude, Phi Beta Kappa
Admissions
- District of Columbia
- South Carolina
- Virginia
- Supreme Court of the United States
- U.S. Court of Appeals for the Fourth Circuit
- U.S. Court of Appeals for the Fifth Circuit
- U.S. Court of Appeals for the Eleventh Circuit
- U.S. District Court, District of Columbia
- U.S. District Court, District of South Carolina
- U.S. District Court, Eastern District of Virginia
Activities
- Member, Law360’s 2025 Product Liability Editorial Advisory Board
-
Member, DRI
- Member, International Consumer Product Health and Safety Organization (ICPHSO)
-
Member, Products Liability Committee of the ABA
-
Member, The Woman Advocate Committee of the ABA